|
Index of reports
> Cases resulting in death (62)
> Cases with Cardio-Respiratory Arrest (7)
Below is the selection of adverse event reports related to Lipitor (Atorvastatin) that includes cases resulting in death where reactions include cardio-respiratory arrest.
Adverse event in 80 year old female receiving Lipitor (Atorvastatin)
Reported by a consumer/non-health professional from Philippines on 2007-06-14
Patient: 80 year old female
Adverse reactions / side effects: Cardio-Respiratory Arrest, Acute Myocardial Infarction
Adverse event resulted in: death
Suspect drug(s):
Lipitor
Administration route: Oral
Norvasc
Administration route: Oral
Adverse event in male receiving Lipitor (Atorvastatin)
Reported by a physician from Japan on 2007-04-27
Patient: male, weighing 52.0 kg (114.4 pounds)
Adverse reactions / side effects: Cardio-Respiratory Arrest, Disease Recurrence, Myocardial Infarction, Thrombosis in Device, Stevens-Johnson Syndrome
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Gaster D
Administration route: Oral
Indication: Gastrointestinal Haemorrhage
Start date: 2006-10-03
End date: 2006-10-26
Lipitor
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2006-09-30
End date: 2006-10-26
Renivace
Administration route: Oral
Indication: Hypertension
Start date: 2006-09-27
End date: 2006-10-25
Aspirin
Administration route: Oral
Indication: Coronary Arterial Stent Insertion
Start date: 2006-09-27
End date: 2006-10-25
Aspirin
Administration route: Oral
Indication: Myocardial Infarction
Start date: 2006-09-27
End date: 2006-10-25
Plavix
Administration route: Oral
Indication: Coronary Arterial Stent Insertion
Start date: 2006-09-27
End date: 2006-10-29
Plavix
Administration route: Oral
Indication: Myocardial Infarction
Start date: 2006-09-27
End date: 2006-10-29
Other drugs received by patient: Artist; Luprac; Sigmart
Adverse event in 65 year old male receiving Lipitor (Atorvastatin)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-02-26
Patient: 65 year old male
Adverse reactions / side effects: Ultrasound Scan Abnormal, Alanine Aminotransferase Increased, Incorrect Dose Administered, Skin Disorder, High Density Lipoprotein Decreased, Flushing, Haemoglobin Decreased, Glycosylated Haemoglobin Increased, Cardio-Respiratory Arrest, Aspartate Aminotransferase Increased, Depressed Level of Consciousness, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: death
Suspect drug(s):
Lorazepam
Dosage: 2 mg q day; po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Niaspan
Dosage: 1000 mg once;po
Administration route: Oral
Indication: High Density Lipoprotein Decreased
Start date: 2006-06-11
End date: 2006-06-11
Niaspan
Dosage: 1000 mg once;po
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2006-06-11
End date: 2006-06-11
Effexor XR
Dosage: 150 mg q day; po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Actos
Dosage: 45 mg q day;po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Glucophage
Dosage: 1000 mg bid;po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Glucotrol XL
Dosage: 10 mg q day;po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Lanoxin
Dosage: 0.375 mg q day;po
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Lantus
Dosage: 70 u q day;sc
Indication: Diabetes Mellitus
Start date: 2006-06-09
End date: 2006-06-11
Lantus
Dosage: 65 u q day;sc
Indication: Diabetes Mellitus
End date: 2006-06-08
Lipitor
Dosage: df;
End date: 2006-06-11
Tenormin
Dosage: 1000 mg q day;po
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Trazodone HCL
Dosage: 200 mg q day;po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Tricor
Dosage: 160 mg q day;po
Administration route: Oral
Indication: Dyslipidaemia
End date: 2006-06-11
Wellbutrin
Dosage: 300 mg q day;po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Risperdal
Dosage: 3 mg; po
Administration route: Oral
Multi-Vitamins
Dosage: df;
Adverse event in 65 year old male receiving Lipitor (Atorvastatin)
Reported by a physician from United States on 2007-02-16
Patient: 65 year old male, weighing 94.8 kg (208.6 pounds)
Adverse reactions / side effects: Flushing, Cardio-Respiratory Arrest, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: death
Suspect drug(s):
Niaspan
Dosage: 1000 mg qd po
Administration route: Oral
Indication: Blood Cholesterol Increased
Start date: 2006-06-11
End date: 2006-06-11
Niaspan
Dosage: 1000 mg qd po
Administration route: Oral
Indication: High Density Lipoprotein Decreased
Start date: 2006-06-11
End date: 2006-06-11
Wellbutrin
Dosage: 300 mg qd po
Administration route: Oral
Indication: Depression
Effexor
Dosage: 150 mg daily po
Administration route: Oral
Indication: Depression
Lorazepam
Dosage: 2 mg qd po
Administration route: Oral
Indication: Depression
Trazodone HCL
Dosage: 200 mg qd po
Administration route: Oral
Indication: Depression
Tenormin
Dosage: 100 mg qd po
Administration route: Oral
Indication: Tachyarrhythmia
Lanoxin
Dosage: 0.375 mg qd po
Administration route: Oral
Glucophage
Dosage: 1000 mg bid po
Administration route: Oral
Glucotrol XL
Dosage: 10 mg qd po
Administration route: Oral
Actos
Dosage: 45 mg qd po
Administration route: Oral
Tricor
Dosage: 160 mg qd po
Administration route: Oral
Lantus
Dosage: 70 qd sc
Start date: 2006-06-09
Lipitor
Vitamin CAP
Risperdal
Dosage: 3 mg po
Administration route: Oral
Adverse event in 65 year old male receiving Lipitor (Atorvastatin)
Reported by a individual with unspecified qualification from United States on 2007-02-07
Patient: 65 year old male
Adverse reactions / side effects: Alanine Aminotransferase Increased, Pallor, High Density Lipoprotein Decreased, Hepatic Steatosis, Flushing, Haemoglobin Decreased, Cardio-Respiratory Arrest, Aspartate Aminotransferase Increased, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: death
Suspect drug(s):
Lorazepam
Dosage: 2 mg q day po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Niaspan
Dosage: 1000 mg once po
Administration route: Oral
Indication: High Density Lipoprotein Decreased
Start date: 2006-06-11
End date: 2006-06-11
Niaspan
Dosage: 1000 mg once po
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2006-06-11
End date: 2006-06-11
Niaspan
Dosage: 500 mg q day po
Administration route: Oral
Indication: High Density Lipoprotein Decreased
Niaspan
Dosage: 500 mg q day po
Administration route: Oral
Indication: Hypercholesterolaemia
Effexor XR
Dosage: 150 mg q day po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Actos
Dosage: 45 mg q day po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Glucophage
Dosage: 1000 mg bid po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Glucotrol XL
Dosage: 10 mg q day po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Lanoxin
Dosage: 0.375 g q day po
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Lantus
Dosage: 70 u q day sc
Indication: Diabetes Mellitus
Start date: 2006-06-09
End date: 2006-06-11
Lantus
Dosage: 65 u q day sc
Indication: Diabetes Mellitus
End date: 2006-06-08
Lipitor
Dosage: df
End date: 2006-06-11
Tenormin
Dosage: 100 mg q day po
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Trazodone HCL
Dosage: 200 mg q day po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Tricor
Dosage: 160 mg q day po
Administration route: Oral
Indication: Dyslipidaemia
End date: 2006-06-11
Wellbutrin
Dosage: 300 mg q day po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Risperdal
Dosage: 3 mg po
Administration route: Oral
Vitamin CAP
Dosage: df
Adverse event in 65 year old male receiving Lipitor (Atorvastatin)
Reported by a physician from United States on 2007-01-31
Patient: 65 year old male, weighing 94.8 kg (208.6 pounds)
Adverse reactions / side effects: Cardio-Respiratory Arrest, Myocardial Infarction
Adverse event resulted in: death
Suspect drug(s):
Actos
Dosage: 45 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2003-07-01
End date: 2006-06-11
Niaspan
Dosage: 1000 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Blood Cholesterol Increased
Start date: 2006-06-11
End date: 2006-06-11
Niaspan
Dosage: 1000 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: High Density Lipoprotein Decreased
Start date: 2006-06-11
End date: 2006-06-11
Wellbutrin
Dosage: 300 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Effexor
Dosage: 150 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Lorazepam
Dosage: 2 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Trazodone HCL
Dosage: 200 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Tenormin
Dosage: 100 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Lanoxin
Dosage: 0.375 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Glucophage
Dosage: 1000 mg, 2 in 1 d, per oral
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Glucotrol XL
Dosage: 10 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Tricor
Dosage: 160 mg, 1 in 1 d, per oral
Administration route: Oral
Indication: Dyslipidaemia
End date: 2006-06-11
Lantus
Dosage: see image
Indication: Diabetes Mellitus
End date: 2006-06-09
Lantus
Dosage: see image
Indication: Diabetes Mellitus
Start date: 2006-06-09
End date: 2006-06-11
Lipitor
End date: 2006-06-11
Multivitamin
End date: 2006-06-11
Risperdal
Dosage: 3 mg, per oral
Administration route: Oral
End date: 2006-06-11
Adverse event in 35 year old male receiving Lipitor (Atorvastatin)
Reported by a pharmacist from United States on 2007-01-02
Patient: 35 year old male, weighing 129.7 kg (285.4 pounds)
Adverse reactions / side effects: Alanine Aminotransferase Increased, Hyperhidrosis, Loss of Consciousness, Abdominal Pain Upper, Anxiety, Burning Sensation, Cardio-Respiratory Arrest, Heart Rate Decreased, Aspartate Aminotransferase Increased
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Lipitor
Indication: Hypercholesterolaemia
Acetadote
Dosage: 19.5 grams x 1 iv bolus
Indication: Hepatic Failure
Start date: 2006-08-20
End date: 2006-08-20
Enzyte
Dosage: 2 months
Indication: Erectile Dysfunction
|
